These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 1577664

  • 1. Synthesis and antitumor activity of 4'-O-acylanthracyclines.
    Nakajima S, Kawai H, Komeshima N, Sakakibara M, Tatsuta K, Otake N, Umezawa H.
    J Antibiot (Tokyo); 1992 Mar; 45(3):374-9. PubMed ID: 1577664
    [Abstract] [Full Text] [Related]

  • 2. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS, Leont'eva OV, Bernaki PD, Olsuf'eva EN, Salimova EI, Pera P, Preobrazhenskaia MN.
    Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
    [Abstract] [Full Text] [Related]

  • 3. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
    Mosher CW, Wu HY, Fujiwara AN, Acton EM.
    J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N, Blake C, Broadhurst MJ, Bushnell DJ, Hassall CH, Hartmann HR, Keech E, Stratton AR, Thomas GJ.
    J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B, Dzieduszycka M, Bontemps-Gracz M, Borowski E, Martelli S.
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
    Kimura Y, Matsumoto T, Suzuki M, Terashima S.
    J Antibiot (Tokyo); 1985 Sep; 38(9):1277-9. PubMed ID: 4066509
    [No Abstract] [Full Text] [Related]

  • 7. 3'-Hydroxyesorubicin halogenated at C-2'.
    Priebe W, Neamati N, Perez-soler R.
    J Antibiot (Tokyo); 1992 Mar; 45(3):386-93. PubMed ID: 1577666
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of new morpholino anthracyclines.
    Komeshima N, Tsuruo T, Umezawa H.
    J Antibiot (Tokyo); 1988 Apr; 41(4):548-53. PubMed ID: 3163685
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antitumor activity of novel C-8 ester derivatives of leinamycin.
    Kanda Y, Ashizawa T, Kawashima K, Ikeda S, Tamaoki T.
    Bioorg Med Chem Lett; 2003 Feb 10; 13(3):455-8. PubMed ID: 12565949
    [Abstract] [Full Text] [Related]

  • 16. 14-esters of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone: synthesis and antitumor activity.
    Horton D, Priebe W.
    J Antibiot (Tokyo); 1983 Sep 10; 36(9):1211-5. PubMed ID: 6630080
    [Abstract] [Full Text] [Related]

  • 17. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
    Cassinelli G, Rivola G, Ruggieri D, Arcamone F, Grein A, Merli S, Spalla C, Casazza AM, Di Marco A, Pratesi G.
    J Antibiot (Tokyo); 1982 Feb 10; 35(2):176-83. PubMed ID: 6951826
    [Abstract] [Full Text] [Related]

  • 18. Intensely potent morpholinyl anthracyclines.
    Acton EM, Tong GL, Mosher CW, Wolgemuth RL.
    J Med Chem; 1984 May 10; 27(5):638-45. PubMed ID: 6716401
    [Abstract] [Full Text] [Related]

  • 19. [Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
    Povarov LS, Bakina EV, Lazhko EI, Orlova GI, Zhukova OS, Obidniak NA, Iurchenko GI, Glazkova TIu, Preobrazhenskaia MN.
    Bioorg Khim; 1990 Apr 10; 16(4):559-68. PubMed ID: 2375780
    [Abstract] [Full Text] [Related]

  • 20. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan 10; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.